Antisense Oligonucleotides in the Treatment of Cerebral Gliomas. Review of Concerning Patents

Publisher： Bentham Science Publishers

E-ISSN： 2212-3954|9|1|2-12

ISSN： 1574-8898

Source： Recent Patents on CNS Drug Discovery, Vol.9, Iss.1, 2014-04, pp. : 2-12

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Antisense Oligonucleotides as an Innovative Therapeutic Strategy in the Treatment of High-Grade Gliomas

By  

Recent Patents on CNS Drug Discovery, Vol. 5, Iss. 1, 2010-01 ,pp. : 53-69

Bentham Science Publishers

Access to resources Recommend Favorite

Making sense of antisense oligonucleotides: A narrative review

By  

MUSCLE AND NERVE, Vol. 57, Iss. 3, 2018-03 ,pp. : 356-370

John Wiley & Sons Inc

Access to resources Recommend Favorite

Treatment of adjuvant arthritis using microencapsulated antisense NF-κB oligonucleotides

By Akhavein Nima   Oettinger Carl   Gayakwad Sanjay   Addo Richard   Bejugam Naveen   Bauer John   Do Duc   Pollock Stanley   D'souza Martin  

Journal of Microencapsulation, Vol. 26, Iss. 3, 2009-05 ,pp. : 223-234

Informa Healthcare

Access to resources Recommend Favorite

Antisense Strategies in Therapy of Gliomas

By  

Current Signal Transduction Therapy, Vol. 6, Iss. 3, 2011-09 ,pp. : 411-423

Bentham Science Publishers

Access to resources Recommend Favorite

Applications of Nanomaterials for Cancer Treatment: Recent Patents Review

By  

Recent Patents on Nanomedicine, Vol. 3, Iss. 2, 2013-01 ,pp. : 75-82

Bentham Science Publishers

Access to resources Recommend Favorite